SILEXION THERAPEUTICS CORP (SLXN) Stock Cash Flow
NASDAQ:SLXN - Nasdaq - KYG1281K1224 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -528.00K | 263.10K | 580.00K | -760.00K | -200.00K | |||
| Change In Working Capital | -62.50K | 64.40K | 360.00K | -470.00K | 120.00K | |||
| Other non cash items | 7.70K | -21.10K | -130.00K | -180.00K | N/A | |||
| OPERATING CASH FLOW | -582.50K | 306.40K | 820.00K | -1.41M | -80.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.24M | 1.65M | 890.00K | 150.00K | 150.00K | |||
| Stock Issued/Repurchased | -22.15M | -112.90M | 0.00 | 118.80M | 30.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | -2.55M | -50.00K | |||
| FINANCING CASH FLOW | -20.92M | -111.25M | 890.00K | 116.40M | 130.00K | |||
| CHANGE IN CASH | -21.50M | -110.95M | 1.71M | 114.99M | 50.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -582.50K | 306.40K | 820.00K | -1.41M | -80.00K | |||
| FREE CASH FLOW | -582.50K | 306.40K | 820.00K | -1.41M | -80.00K | |||
All data in USD